IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Consonance Capital Management LP

Q2 2015 Holdings

Filed 2015-08-12 | 28 holdings | $186.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2015-08-25) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$87.3M1,298,90046.9%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$65.5M1,055,79135.2%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$22.8M5,517,88512.3%
Adma Biologics Inc(ADMA)COM000899104$9.6M1,034,7215.2%
Retrophin IncCOM761299106$112.7K3,400,3230.1%
Insys Therapeutics Inc NewCOM NEW45824V209$107.2K2,984,0940.1%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$95.7K1,183,4060.1%
Akorn Inc(AKRXEUR)COM009728106$80.5K1,843,7560.0%
United Therapeutics Corp del(UTHR)COM91307C102$67.4K387,1860.0%
Cardiovascular SYS Inc del(CSIIEUR)COM141619106$65.5K2,476,2870.0%
Orthofix Intl N VCOMN6748L102$57.2K1,725,6970.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$55.8K1,241,3210.0%
Pacific Biosciences Calif in(PACB)COM69404D108$31.1K5,398,8610.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$26.6K303,1310.0%
Osiris Therapeutics Inc NewCOM68827R108$22.9K1,176,1950.0%
Celldex Therapeutics Inc NewCOM15117B103$19.0K751,7480.0%
Epirus Biopharmaceuticals inCOM29428P107$12.9K2,265,9880.0%
Derma Sciences IncCOM PAR $.01249827502$12.6K1,760,6490.0%
Healthways IncCOM422245100$12.1K1,010,0250.0%
Vericel Corp(VCEL)ACOM92346J108$8.4K2,352,9400.0%
Nanostring Technologies Inc(NSTGEUR)COM63009R109$6.9K449,3250.0%
Merus Labs Intl Inc NewCOM59047R101$3.8K1,641,5880.0%
Sientra IncCOM82621J105$3.3K132,1350.0%
Veracyte Inc(VCYT)ACOM92337F107$3.3K298,9660.0%
Biotime Inc(BTXUSD)COM09066L105$2.4K655,5400.0%
Imprivata IncCOM45323J103$1.6K95,7590.0%
Biolase IncCOM090911108$1.2K667,6640.0%
Ehealth Inc(EHTH)COM28238P109$675,2420.0%